Bank of America Securities Reaffirms Their Hold Rating on ACADIA Pharmaceuticals (ACAD)
Bank of America Securities analyst Tazeen Ahmad reiterated a Hold rating on ACADIA Pharmaceuticals (ACAD – Research Report) yesterday and set a price target of $18.00. The company's shares closed yesterday at $17.16.
Confident Investing Starts Here:
Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Ahmad covers the Healthcare sector, focusing on stocks such as Sarepta Therapeutics, PTC Therapeutics, and Alnylam Pharma. According to TipRanks, Ahmad has an average return of -5.3% and a 43.00% success rate on recommended stocks.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for ACADIA Pharmaceuticals with a $25.44 average price target, which is a 48.25% upside from current levels. In a report released on May 8, Stifel Nicolaus also maintained a Hold rating on the stock with a $18.00 price target.
Based on ACADIA Pharmaceuticals' latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $244.32 million and a net profit of $18.99 million. In comparison, last year the company earned a revenue of $205.83 million and had a net profit of $16.56 million
Based on the recent corporate insider activity of 29 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of ACAD in relation to earlier this year. Most recently, in March 2025, ELIZABETH A. GAROFALO, a Director at ACAD sold 4,919.00 shares for a total of $89,673.37.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
an hour ago
- Business Insider
Meme Stock GameStop (GME) Is About to Report Q1 Earnings Tomorrow. Here Is What to Expect
Video game retailer GameStop (GME) is set to report its quarterly earnings results tomorrow, June 10. The stock has surged about 32% over the past three months, thanks to meme stock revival and the company's surprise investment in Bitcoin (BTC). This recent momentum comes even as concerns linger over the long-term outlook for GameStop's core gaming operations. Confident Investing Starts Here: Wall Street analysts expect the company to report earnings of $0.08 per share, versus a loss of $0.12 in the year-ago quarter. However, revenues are expected to decline by 15% from the year-ago quarter to $750 million, according to data from the TipRanks Forecast page. Recent Event Ahead of the Q1 2025 print, GameStop invested in Bitcoin, following a strategy similar to Michael Saylor's Strategy (MSTR), a software company that turned into a serial Bitcoin acquirer. In a late-May filing, GameStop revealed it had purchased 4,710 Bitcoins valued at $513 million. The acquisition marked GameStop's first Bitcoin purchase since it unveiled its plans in March to start investing in crypto. As earnings approach, investors will be watching closely for any updates on the company's digital strategy and sales trends in its retail segment. GME's Q4 Shows Profit Surprise In the last reported Q4 quarter, GameStop surprised with an earnings per share (EPS) of $0.30, far ahead of Wall Street's $0.08 estimate. The company posted a full-year profit of $131.3 million in 2024, a sharp turnaround from just $6.7 million the year before, mainly due to aggressive cost-cutting efforts. However, revenue dropped 28.5% year-over-year to $1.28 billion in Q4, missing analyst expectations of $1.48 billion. Full-year revenue came in at $3.82 billion, down from $5.27 billion in 2023. The company continues to see weakness in its core video game hardware and software segments. According to Main Street Data, GME's Hardware and Accessories segment has been on a downward trend, with recent quarters showing significant declines from earlier levels. Options Traders Anticipate a Large Move Using TipRanks' Options tool, we can see what options traders are expecting from the stock immediately after its earnings report. The expected earnings move is determined by calculating the at-the-money straddle of the options closest to expiration after the earnings announcement. If this sounds complicated, don't worry, the Options tool does this for you. Indeed, it currently says that options traders are expecting an 11.05% move in either direction. Is GME Stock a Buy, Sell, or Hold? GameStop's fundamentals and unpredictable trading patterns have led many Wall Street analysts to take a step back from covering the stock. One of the few analysts still covering this stock is Michael Pachter of Wedbush, who continues to maintain a Sell rating. According to him, he sees more than 54% downside for GameStop based on his price target of $13.5 per share.
Business Insider
3 hours ago
- Business Insider
‘Keep an Eye on the Bigger Picture,' Says Morgan Stanley About Tesla Stock
Tesla (NASDAQ:TSLA) stock took a sharp hit last week after Elon Musk and Donald Trump – once close buddies – turned on each other in a public social media spat that quickly became an online spectacle. While the internet grabbed its popcorn to watch the drama/comedy unfold, investors were less amused, driving the stock down and wiping out a record $152 billion in market value. Confident Investing Starts Here: Trump warned he might yank Elon's federal subsidies and contracts, while Musk took jabs at Trump's links to Jeffrey Epstein and called for his impeachment. Now, Trump says he's considering ditching his Tesla. But what does Wall Street have to say about all this madness? Morgan Stanley analyst Adam Jonas, one of the Street's biggest TSLA bulls, shared a 'few 'pith and marrow' thoughts' in the wake of the public spat. According to Trump, the whole thing kicked off because Musk was upset his 'Big Beautiful Bill' was not beneficial to Tesla. However, Jonas makes short shrift of the implications. 'We do not believe the phasing out of EV tax credits from the BBB (Big Beautiful Bill) is material to the long term outlook for TSLA,' the analyst said While Musk's involvement with the Trump administration and his increasingly polarizing politics were the cue from a massive drop in sales for Tesla earlier this year, Jonas does not think the argument will help bring back buyers that once considered buying a Tesla but were turned off by Musk's recent activities. In fact, Jonas thinks the argument could 'potentially (temporarily) alienate multiple sides of the political spectrum.' Yet, zooming out, Jonas thinks it's important to keep an eye on the bigger picture and that offers plenty of promise. 'While emotions are running high, we are not convinced the longer-term vectors that drive the stock's value have changed here,' he said. ' AI leadership, autonomy/robotics, manufacturing, supply chain re-architecture, renewable power, critical infrastructure… Tesla still holds so many valuable cards that are largely apolitical, in our opinion.' Nevertheless, investors should prepare for a rocky ride over the near-term. Donning his 'trading cap,' Jonas feels more confident about short-term volatility than about the stock's immediate direction. The analyst says he's sticking with his $410 price target on Tesla shares, even as he braces for the stock to post further losses. That figure implies a one-year gain of 36%. Meanwhile, Jonas maintains an Overweight rating (i.e., Buy). (To watch Jonas' track record, click here) That view, however, stands in contrast to the broader Street sentiment. Based on a mix of 16 Buys, 10 Holds, and 10 Sells, the analyst consensus rates the stock a Hold (i.e., Neutral). Going by the $285.91 average target, the shares are expected stay range-bound for the foreseeable future. (See TSLA stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.
Business Insider
3 hours ago
- Business Insider
Petrobras downgraded to Neutral from Outperform at Grupo Santander
Grupo Santander downgraded Petrobras (PBR) to Neutral from Outperform with a $13 price target The firm cites lower yields and capital structure concerns for the downgrade. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
